Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Upstream integration of implementation planning in clinical trials through the blood and marrow transplant clinical trials network

Anna Desalvo, Brittany Ragon, Neel Bhatt, Betty K. Hamilton, Azra Borogovac, Mary Horowitz, Nandita Khera, Mark Juckett, Steven Devine, Christopher Dandoy, Alla Keyzner, Yvonne Efebera, John Plastaras, Mitchell Horwitz, Sarah Wall, Valerie Stewart, Mykala Heuer, Todd Molfenter

Blood (2025) 146 (Supplement 1): 7913.

https://doi.org/10.1182/blood-2025-7913

Published: 2025

Journal Articles

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Colleen Kelly, Morgan Paul, Wendy London, Rahela Aziz-Bose, Puja Umaretiya, Erica Esrick, Victoria Coleman-Cowger, Gary Schiller, Mehrdad Abedi, Joseph Antin, Mary Horowitz, Neena Kapoor, Edmund Waller, Sonali Chaudhury, Mary Eapen, Mark Walters, David Williams, Kira Bona

Blood (2025) 146 (Supplement 1): 6224.

https://doi.org/10.1182/blood-2025-6224

Published: 2025

Journal Articles

Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study.

Blood (2025) 146 (Supplement 1): 4198.

https://doi.org/10.1182/blood-2025-4198

Published: 2025

Journal Articles

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Blood (2025) 146 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2025-1058

Published: 2025

Journal Articles

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Blood (2025) 146 (Supplement 1): 818.

https://doi.org/10.1182/blood-2025-818

Published: 2025

Journal Articles

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

Blood (2025) 146 (Supplement 1): 170.

https://doi.org/10.1182/blood-2025-170

Published: 2025

Journal Articles

Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a

Blood (2025) 146 (Supplement 1): 6094.

https://doi.org/10.1182/blood-2025-6094

Published: 2025

Journal Articles

HLA-DQ heterodimers in hematopoietic cell transplantation

Effie W. Petersdorf, Mats Bengtsson, Mary Horowitz, Caroline McKallor, Stephen R. Spellman, Eric Spierings, Ted A. Gooley, Phil Stevenson, on behalf of the International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Blood (2022) 139 (20): 3009–3017.

https://doi.org/10.1182/blood.2022015860

Published: 2022

Includes: Supplemental data

Journal Articles

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Effie W. Petersdorf, Philip Stevenson, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J. Alejandro Madrigal, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R. Spellman, Jean Villard, Mary Carrington

Blood (2020) 136 (3): 362–369.

https://doi.org/10.1182/blood.2020005743

Published: 2020

Includes: Supplemental data

Journal Articles

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Corey Cutler, Kristen Stevenson, Haesook T. Kim, Paul Richardson, Vincent T. Ho, Erica Linden, Carolyn Revta, Ruth Ebert, Diane Warren, Sung Choi, John Koreth, Philippe Armand, Edwin Alyea, Shelly Carter, Mary Horowitz, Joseph H. Antin, Robert Soiffer

Blood (2008) 112 (12): 4425–4431.

https://doi.org/10.1182/blood-2008-07-169342

Published: 2008

Journal Articles

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Stephanie J. Lee, John Klein, Michael Haagenson, Lee Ann Baxter-Lowe, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Neal Flomenberg, Mary Horowitz, Carolyn K. Hurley, Harriet Noreen, Machteld Oudshoorn, Effie Petersdorf, Michelle Setterholm, Stephen Spellman, Daniel Weisdorf, Thomas M. Williams, Claudio Anasetti

Blood (2007) 110 (13): 4576–4583.

https://doi.org/10.1182/blood-2007-06-097386

Published: 2007

Includes: Supplemental data

Journal Articles

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Daniel J. Weisdorf, MD, Stephen Spellman, John Klein, PhD, Michael D. Haagenson, MS, Mary Horowitz, MD, Stephanie Lee, MD, MPH, Claudio Anasetti, MD, Michelle Setterholm, Rebecca Drexler, BS, AAS, Martin Maiers, Roberta King, Dennis Confer, MD

Blood (2007) 110 (11): 45.

https://doi.org/10.1182/blood.V110.11.45.45

Published: 2007

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with Malignant and Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR).

Vikas Gupta, Marcie Tomblyn, Tanya Pederson, Jill Thompson, Ron Gress, Jan Storek, Jo-Anne van Burik, Mary Horowitz, Armand Keating

Blood (2006) 108 (11): 5353.

https://doi.org/10.1182/blood.V108.11.5353.5353

Published: 2006

Journal Articles

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Jeffrey S. Miller, MD, Sarah Cooley, MD, Peter Parham, PhD, Michael R. Verneris, MD, Karina McQueen, Libby Guethlein, Sherif Farag, MD, Michael Haagenson, Mary Horowitz, MD, John Klein, PhD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 171.

https://doi.org/10.1182/blood.V108.11.171.171

Published: 2006

Journal Articles

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Stephanie J. Lee, MD, MPH, John Klein, PhD, Michael Haagenson, MS, Lee Ann Baxter-Lowe, PhD, Dennis Confer, MD, Mary Eapen, MBBS, Marcelo Fernandez-Vina, PhD, Neal Flomenberg, MD, Mary Horowitz, MD, Carolyn Hurley, PhD, Harriet Noreen, CHS, Machteld Oudshoorn, PhD, Effie Petersdorf, MD, Michelle Setterholm, MS, Stephen Spellman, MS, Daniel Weisdorf, MD, Thomas M. Williams, MD, Claudio Anasetti, MD

Blood (2006) 108 (11): 172.

https://doi.org/10.1182/blood.V108.11.172.172

Published: 2006

Journal Articles

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Michele Baccarani, Giuseppe Saglio, John Goldman, Andreas Hochhaus, Bengt Simonsson, Frederick Appelbaum, Jane Apperley, Francisco Cervantes, Jorge Cortes, Michael Deininger, Alois Gratwohl, François Guilhot, Mary Horowitz, Timothy Hughes, Hagop Kantarjian, Richard Larson, Dietger Niederwieser, Richard Silver, Rudiger Hehlmann

Blood (2006) 108 (6): 1809–1820.

https://doi.org/10.1182/blood-2006-02-005686

Published: 2006

Journal Articles

Use of Peripheral Blood Grafts Is Associated with Increased Acute and Chronic Graft-Versus-Host Disease without Improved Survival after Unrelated Donor Transplantation.

Mary Eapen, MBBS, Michael Haagenson, MS, Brent Logan, PhD, Dennis Confer, MD, Mary Horowitz, MD, John Wagner, MD, Daniel Weisdorf, MD, Claudio Anasetti, MD

Blood (2005) 106 (11): 443.

https://doi.org/10.1182/blood.V106.11.443.443

Published: 2005

Journal Articles

Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM).

Pablo Rubinstein, MD, Mary Eapen, MBBS, Cladd Stevens, MD, Joanne Kurtzberg, MD, Andromachi Scaradavou, MD, John Klein, PhD, Mary Horowitz, MD, John Wagner, MD

Blood (2005) 106 (11): 302.

https://doi.org/10.1182/blood.V106.11.302.302

Published: 2005

Journal Articles

Impact of Prior Pregnancy on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Alison Wakoff Loren, MD, MSCE, Greta R. Bunin, PhD, Christian Boudreau, PhD, Richard E. Champlin, MD, Avital Cnaan, PhD, Mary Horowitz, MD, MS, Fausto Loberiza, MD, MS, David L. Porter, MD

Blood (2004) 104 (11): 1638.

https://doi.org/10.1182/blood.V104.11.1638.1638

Published: 2004

Journal Articles

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Neal Flomenberg, Lee Ann Baxter-Lowe, Dennis Confer, Marcelo Fernandez-Vina, Alexandra Filipovich, Mary Horowitz, Carolyn Hurley, Craig Kollman, Claudio Anasetti, Harriet Noreen, Ann Begovich, William Hildebrand, Effie Petersdorf, Barbara Schmeckpeper, Michelle Setterholm, Elizabeth Trachtenberg, Thomas Williams, Edmond Yunis, Daniel Weisdorf

Blood (2004) 104 (7): 1923–1930.

https://doi.org/10.1182/blood-2004-03-0803

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Upstream integration of implementation planning in clinical trials through the blood and marrow transplant clinical trials network

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study.

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a

HLA-DQ heterodimers in hematopoietic cell transplantation

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with Malignant and Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR).

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Use of Peripheral Blood Grafts Is Associated with Increased Acute and Chronic Graft-Versus-Host Disease without Improved Survival after Unrelated Donor Transplantation.

Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM).

Impact of Prior Pregnancy on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only